Keyphrases
Calcium Channel Blockers
100%
Network Meta-analysis
80%
Confidence Interval
66%
Systematic Meta-analysis
64%
Nested Case-control Study
60%
Population-based
60%
Odds Ratio
51%
Cardiovascular Risk
40%
Prostate Cancer
40%
Meta-analysis
29%
Lung Cancer Risk
27%
Lung Cancer
23%
Safety Outcomes
22%
Efficacy Outcomes
22%
Meta-regression
21%
Once-daily
20%
Enhancement Mechanism
20%
Empirical Therapy
20%
Gentamicin
20%
Systemic Thrombolysis
20%
Intestinal Permeability
20%
Jerusalem
20%
Clamping Method
20%
Systemic Anticoagulation
20%
AIDS/HIV
20%
Nirmatrelvir
20%
COVID-19 Outpatients
20%
Polar Molecules
20%
Antiviral Treatment
20%
Catheter-directed Thrombolysis
20%
Meta-analysis Regression
20%
Fluoroquinolones
20%
Hospitalization
20%
Pediatric Cancer Patients
20%
Intermediate-risk Pulmonary Embolism
20%
People Living with HIV (PLHIV)
20%
High-risk Pulmonary Embolism
20%
Molnupiravir
20%
Symptomatic COVID-19
20%
Patient Survey
20%
Sodium
20%
Cardiovascular Mortality
20%
Chronic Coronary Artery Disease
20%
Meta-network
20%
Cefonicid
20%
Indwelling Central Venous Catheter
20%
Remdesivir
20%
Non-neutropenic
20%
Amino
20%
Voltage Clamp
20%
Pharmacology, Toxicology and Pharmaceutical Science
Calcium Channel Blocker
100%
Case-Control Study
60%
Lung Cancer
40%
Cardiovascular Risk
40%
Prostate Cancer
40%
Randomized Controlled Trial
29%
Observational Study
24%
Intestinal Permeability
20%
Antivirus Agent
20%
Lung Embolism
20%
Bleeding
20%
Malignant Neoplasm
20%
Coronary Artery Disease
20%
Nirmatrelvir
20%
Breast Cancer
20%
Gentamicin
20%
Quinolone Derivative
20%
Pregabalin
20%
Remdesivir
20%
Anticoagulant Agent
20%
Coronavirinae
20%
Rivaroxaban
20%
Molnupiravir
20%
Octanoic Acid
20%
Ritonavir
20%
Cancer Incidence
20%
HIV
20%
Diseases
20%
Cefonicid
20%
Macrolide
20%
Heart Infarction
19%
Antiviral Drug
16%
Brain Hemorrhage
16%
Prasugrel
16%
Ticagrelor
16%
Cardiovascular Mortality
15%
Heart Arrhythmia
15%
Bloodstream Infection
13%
Clopidogrel
12%
Random Effects Model
9%
Clinical Trial
9%
Acetylsalicylic Acid
8%
Ischemic Heart Disease
8%
Antithrombotic Therapy
8%
Ethylenediaminetetraacetic Acid
7%
Antihypertensive Drug
7%
Long Term Exposure
7%
Adverse Event
6%
Cohort Study
6%
Cellulitis
6%
Medicine and Dentistry
Systematic Review
40%
Calcium Channel Blocking Agent
40%
Observational Study
21%
Case-Control Study
20%
Pregabalin
20%
HIV/AIDS
20%
Network Meta-Analysis
20%
Prostate Cancer
20%
Anticoagulation
20%
Pulmonary Embolism
20%
Meta-Analysis
20%
Blood Clot Lysis
20%
Cardiovascular Risk
20%
Lung Cancer
20%
Cancer Incidence
20%
Odds Ratio
19%
Health Service
8%
Framingham Risk Score
6%
Antiretroviral Therapy
6%
Major Bleeding
5%
Cerebral Hemorrhage
5%
Antihypertensive Drug
5%
